Asthma is caused by bronchial inflammation. This inflammation involves mucus overproduction and hypersecretion. Recently, a mouse model of asthma showed that gob-5 is involved in the pathogenesis of asthma. The gob-5 gene is involved in mucus secretion and its expression is upregulated upon antigen attack in sensitized mice. The observation suggests that human homologue of gob-5, hCLCA1 (human calcium-dependent chloride channel-1), may be involved in human disease. We screened for single-nucleotide polymorphisms (SNPs) in hCLCA1 in the Japanese population. We identified eight SNPs, and performed association studies using 384 child patients with asthma, 480 adult patients with asthma, and 672 controls. In haplotype analysis, we found a different haplotype distribution pattern between controls and childhood asthma (Po0.0001) and between controls and adult asthma (P ¼ 0.0031). We identified a high-risk haplotype (CATCAAGT haplotype; P ¼ 0.0014) and a low-risk haplotype (TGCCAAGT haplotype; P ¼ 0.00010) in cases of childhood asthma. In diplotype analysis, patients who had the CATCAAGT haplotype showed a higher risk for childhood asthma than those who did not (P ¼ 0.0011). Individuals who had the TGCCAAGT haplotype showed a lower risk for childhood asthma than those who did not (Po0.0001). Our data suggested that variation of the hCLCA1 gene affects patients' susceptibility for asthma.
Introduction
Asthma is a chronic illness characterized by reversible airway obstruction and airway hyper-responsiveness (AHR) that are caused by bronchial inflammation. 1, 2 This inflammation involves epithelial damage, deposition of collagen beneath the basement membrane, eosinophilic and lymphocytic infiltration, and hypertrophy and hyperplasia of goblet cells, submucosal glands, and airway smooth muscle. 3, 4 Ample evidence suggests that a combination of genetic and environmental factors causes asthma. [5] [6] [7] Candidate gene and genome-wide linkage studies have already identified several specific gene polymorphisms, regions of linkage to asthma, and asthma-related phenotypes. 8, 9 Recently, a mouse model of asthma provided the evidence that the gob-5 gene is involved in the pathogenesis of asthma. 10, 11 Nakanishi et al reported that intratracheal administration of adenovirus-expressing antisense gob-5 RNA into AHR-model mice efficiently suppressed the asthma phenotype, including AHR and mucus overproduction, and that an adenovirusmediated overexpression of gob-5 in airway epithelia exacerbated the asthma phenotype. Zhou et al 11 showed that gob-5 is highly expressed in the lung epithelium of IL-9 transgenic mice, which exhibit many signs and symptoms characteristic of human asthma. Asthmatic patients showed upregulation of hCLCA1 (human calcium-dependent chloride channel-1) mRNA in mucusproducing epithelium responsive to the interleukin IL-9. 12 Because IL-9 is one of the Th2 cytokines, these observations suggest the involvement of hCLCA1 in the pathophysiology of Th2 cytokine-mediated asthma. In addition, gob-5 was suggested to be involved in mucus production induced by respiratory syncytial virus infection that has strong impact on asthma pathogenesis.
The human homologue of gob-5 is hCLCA1, which is expressed in intestinal epithelia, uterus, testes, and kidneys where gob-5 is also expressed. 15, 16 The human hCLCA1 gene is one of the members of the Ca 2 þ -activated Cl À channel family. The hCLCA1 enhances mucus secretion by mediating the active transport of chloride ions. 10 Currently, the family includes two bovine homologues (bCLCA1 and bCLCA2), [17] [18] [19] four murine homologues (mCLCA1, mCLCA2, mCLCA3 (gob-5), mCLCA4), [20] [21] [22] [23] [24] and four human homologues (hCLCA1, hCLCA2, hCLCA3, hCLCA4 (hCaCC2)). 15, 16, 25, 26 All human CLCA genes identified are clustered on the short arm of chromosome 1 (1p22-31). 16, 27 The hCLCA1 gene is 31 902 bp in length, contains 15 exons, and encodes a protein of 914 amino acids. 16 Mouse experiments on gob-5 10,11 and observations on bronchial epithelia from asthma patients 12 suggest that overexpression of hCLCA1 in the bronchial epithelia exacerbates AHR and mucus hypersecretion in asthma patients. We therefore hypothesized that polymorphisms that affect expression or function of the hCLCA1 gene would be associated with asthma phenotypes. In this study, we screened single-nucleotide polymorphisms (SNPs) in the hCLCA1 gene and performed case-control and case-only association studies using clinically characterized Japanese patients with childhood or adult asthma.
Results

Characteristics of asthma patients
Clinical characteristics of the patients are described in detail elsewhere. 28 Briefly, 80% of the children with asthma were found to be positive for mite-specific IgE (atopic), 54% were found to have high serum IgE concentrations (4400 U/ml), and 46% were found to have atopic dermatitis. Of the adults with asthma, 28% were found to have high serum IgE concentrations and 22% experienced the onset of asthma before the age of 18 years.
Polymorphisms in the hCLCA1 gene During the course of the Japanese Single Nucleotide Polymorphisms project in Japan (http://snp.ims.u-tokyo.ac.jp/), 29, 30 SNPs were identified in the hCLCA1 gene. Two SNPs were located in exons. One (JST083354) was located in exon 6 and the other (JST046987 (SNP8 in this study)) in exon 15 (Table 1) . Both SNPs were synonymous substitutions (Val215Val and Thr812Thr, respectively). Because the SNP of exon 6 showed complete linkage disequilibrium to SNP2 (JST120332) ( Table 1) in 94 normal samples (data not shown), it was excluded from any further investigation. In addition to the exonic SNPs, seven SNPs found in the introns with a minor allele frequency of more than 20% were investigated in this study (Table 1 ). In the haplotype and diplotype analyses, PHASE and HAPLOTYPER programs showed essentially the same results. Results obtained with PHASE software are shown in Tables 2,  4 , and 5.
To examine the linkage disequilibrium between identified SNPs, pairwise linkage disequilibrium coefficients D 030 and r 231 and P-value were calculated using 592 controls (Table 2 ). Strong but not complete linkage disequilibrium was found between the following pairs: SNP1 and SNP3, SNP2 and SNP3, SNP4 and SNP5, SNP4 and SNP6, and SNP6 and SNP7. Weak linkage disequilibrium was found between the following pairs: SNP1 and SNP7, SNP2 and SNP7, SNP2 and SNP8, SNP4 and SNP8, and SNP5 and SNP7.
Association of each SNP with asthma and asthma related-phenotypes Eight SNPs were genotyped in 384 patients with childhood asthma, 480 patients with adult asthma, and 672 controls. All genotype results of the SNPs in the control samples were in the Hardy-Weinberg equilibrium. The results of case-control and case-only association studies with significant (Po0.01) P-values are shown in Table 3 .
In the case-control study, an association of SNP4 with the most severe cases of adult asthma was observed (odds ratio (OR) ¼ 0.26, 95% confidence interval (CI) ¼ 0.12-0.60, w 2 ¼ 11.43, P ¼ 0.0032, corrected OR (cOR) ¼ 0.15). Both SNP2 and SNP8 showed significant association with aspirin-induced asthma (AIA) (P ¼ 0.0057 and 0.0050, respectively). SNP8 showed some association with adult asthma cases that had a high (410%) eosinophil count (P ¼ 0.0079).
In the case-only study, associations between asthma-related phenotypes and the SNPs of hCLCA1 were investigated within the group of asthma patients. There were significant differences in the genotype frequency of SNP2 and SNP8 between AIA and non-AIA asthma (P ¼ 0.0074 and 0.0084, respectively). We found an association between SNP6 and the complication of atopic dermatitis in childhood asthma (P ¼ 0.0046). There was no significant association between atopy (positive mite-specific IgE) and any SNPs of hCLCA1 among childhood asthma patients, suggesting that hCLCA1 is primarily associated with asthma and/or dermatitis but not atopy.
Association between haplotypes of the hCLCA1 gene and asthma We used eight SNPs to construct the haplotype of the hCLCA1 gene and estimated the frequency of each Table 4 Frequencies of haplotypes constructed from eight SNPs and ORs in the control group and in both asthma groups Association of the hCLCA1 gene with asthma F Kamada et al
As shown in Table 5 , we examined the association of the diplotypes of hCLCA1 with asthma. The results suggested that a heterozygote of haplotype 6 showed a lower risk for childhood asthma (OR ¼ 0.26, CI ¼ 0.14-0.49, w 2 ¼ 20.11, P c o0.0001, cOR ¼ 0.26) and a heterozygote of haplotype 18 showed a higher risk for childhood asthma (OR ¼ 3.56, CI ¼ 1.92-6.58, w 2 ¼ 18.28, P c ¼ 0.0011, cOR ¼ 3.61) when compared to other diplotypes. We next studied the association of diplotypes with patients stratified by the asthma-related phenotypes. Significant associations were found between haplotype 6 and children with high IgE levels (P c o0.0001), positive mite-specific IgE results (P c o0.0001), and early age of asthma onset (o3 years old) (P c ¼ 0.00089). The association between haplotype 18 and childhood asthma was also significant when patients were limited to those with higher IgE levels (P c ¼ 0.0081) or those with severe symptoms (P c ¼ 0.0064). The significance of association between haplotype 22 and adult asthma was marginal (P c ¼ 0.013). In childhood asthma patients, there was no significant association between haplotype 6 or haplotype 18 and atopy, suggesting that these haplotypes are primarily associated with asthma development.
Discussion
We performed case-control and case-only association studies of SNPs in the hCLCA1 gene using clinically characterized asthma patients. When each SNP in hCLCA1 was studied for its association in all asthma samples, no association with childhood asthma or with adult asthma was suggested. However, when patients were stratified by asthma-related phenotypes, subgroups of patients showed associations with SNPs. The genotype frequencies of SNP2 and SNP8 in patients with AIA were different from those of the controls and those of patients without AIA. These data suggest an association of the hCLCA1 gene with AIA and different pathophysiologies between patients with AIA and those without AIA. Because the number of patients with AIA is relatively small, an association study of hCLCA1 with a larger number of patients with AIA may be required to confirm our observation. Adult patients with asthma and high eosinophil counts showed a significant association with SNP8. Because the SNP8 genotype frequency in adults with asthma and a low eosinophil count is similar to that of the controls (data not shown), only adult patients with high eosinophil counts showed different genotype frequencies from controls or other patient groups. The data may reflect different pathophysiologies between patients with eosinophilia and those without eosinophilia. An association was found between SNP6 and the complication of atopic dermatitis among childhood asthma patients. Because atopic dermatitis was closely related with total IgE levels and positive mitespecific IgE status, it is possible that hCLCA1 is involved in atopy or the development of atopic dermatitis. Since we could not detect significant association between hCLCA1 and atopy in the case-only studies, it is likely that hCLCA1 is primarily associated with dermatitis itself. The evidence of association of the hCLCA1 gene with asthma was shown more clearly by the haplotype analyses. The entire distributions of the haplotype frequency in childhood and adult asthma patients were different from that of the controls. The frequency of haplotype 6 was significantly lower in childhood asthma patients than in the controls. From the diplotype construction analysis, individuals who were heterozygous for haplotype 6 showed a lower risk for childhood asthma (OR ¼ 0.26). These data suggest that it is a protective haplotype against asthma development. About 10% of Japanese individuals have this haplotype and they are expected to show a lower susceptibility to childhood asthma than those who do not. On the other hand, the frequency of haplotype 18 was significantly higher in childhood asthma patients than in the controls. From the diplotype analysis, individuals who harbor haplotype 18 showed a higher risk for childhood asthma (OR ¼ 3.56). These data suggest that it is a high-risk haplotype for asthma development. About 3% of Japanese individuals have this haplotype and they are expected to show a higher susceptibility to childhood asthma than those who do not.
Our observations support the results from an earlier AHR-model mice study. The gob-5 mRNA is strongly expressed in the airway epithelium, especially in the goblet cells, the function of which is to secrete mucins. 10 Mucus overproduction is thought to be responsible for the small-airway obstruction and lung dysfunction that are closely linked to morbidity and mortality in asthma cases.
This study is the first to investigate the association between SNPs of the hCLCA1 gene and asthma in humans. It showed evidence of associations between particular haplotypes of the hCLCA1 gene and asthma development in the Japanese population. None of the SNPs investigated in this study change the amino-acid sequence of the hCLCA1 protein. Therefore, it is unlikely that the nucleotide changes per se affect the function of hCLCA1. Any nucleotide changes that are in linkage disequilibrium to this haplotype may exist in or near the hCLCA1 gene. It will be necessary to extend the survey of polymorphisms in the promoter regions as well as introns and exons of the hCLCA1 gene to identify any functional genetic changes. Several studies have reported that there was a significant association between promoter and intronic variants of a gene and a disease. 32, 33 Demonstrating the alteration of gene functions as the result of polymorphisms is necessary to further validate the involvement of the hCLCA1 gene in the pathogenesis of asthma.
While this manuscript was being prepared, the association of hCLCA1 and chronic obstructive lung disease (COLD) in the Japanese population was published. 34 Among the eight SNPs in our study, only one SNP (SNP8) was also investigated in Hegab's study; therefore, the comparison of results between our studies is difficult. Association of hCLCA1 with both asthma and COLD may imply a common pathogenic background between these two diseases.
Materials and methods
Subjects
We recruited 384 children with asthma and 96 adults with asthma from Osaka Prefectural Habikino Hospital and another 384 adults with asthma from the Miyatake Asthma Clinic. Details of these patients are described elsewhere. 28 All participants with asthma were selected according to the American Thoracic Society criteria. 35 Regarding the children with asthma, we recorded their age, sex, age at asthma onset, serum total IgE level, mitespecific IgE level, eosinophil count, clinical severity, incidence of atopic dermatitis, and the number of parents and siblings affected with asthma. Specific IgE was considered positive when values exceeded 0.35 U A /ml (RAST score X1) according to an enzyme immunoassay. The severity of childhood asthma was defined according to the degree of therapy required to control symptoms at the time of entry into this study. The grades were defined as follows: Grade 1, b stimulants only; Grade 2, sodium chromoglycate and/or theophylline; Grade 3, inhaled beclometasone, 400 mg/day or less; and Grade 4, inhaled beclometasone of more than 400 mg/day. Regarding the adults with asthma, we recorded their age, sex, age at asthma onset, serum total IgE level, eosinophil count, clinical severity, incidence of AIA, presence or absence of nasal polyps, and the number of relatives second-degree or closer with asthma. The severity of adult asthma was classified according to the system from the National Heart, Lung, and Blood Institute. 36 In this study, patients who were under 18 years of age at the time of entry were classified as having childhood asthma and those who were 18 years of age or older were classified as having adult asthma regardless of their age at the time of onset. We selected 672 control subjects who did not have atopyrelated diseases from the general population in the Tokyo and Osaka areas. Genomic DNAs were prepared in accordance with standard protocols. All patients and volunteers provided written informed consent to participate in the study in accordance with the rules of the process committee at the SNP Research Center (RIKEN) and the Tohoku University School of Medicine.
SNP genotyping
Genotyping of SNPs was performed by using the Invader assay 37, 38 or the TaqMant allele-specific amplification (TaqMan-ASA) method. 39 Specific primers were designed on the basis of genomic sequences obtained from the GenBank DNA database (accession number AF039401). The primer sequences and genotyping methods are shown in Table 6 . The mixture for the Invader assay contained 5 ng of genomic DNA, 1.25 mM dNTPs, 5.9 mM MgCl 2 , 16.6 mM (NH 4 ) 2 SO 4 , 67 mM TrisHCl (pH 8.8), 10 mM b-mercaptoethanol, a pair of specific primers (12.5 pmol each), and Ex-Taq DNA polymerase (0.5 U; TaKaRa, Japan) in a final volume of 10 ml. Samples were amplified in the GeneAmpt PCR system 9700 (Applied Biosystems, USA). Thermoprofiles were initial denaturation at 951C for 2 min, followed by 37 cycles of denaturing at 941C for 30 s, annealing at 601C for 30 s, and extension at 721C for 3 min, with a final extension at 721C for 10 min. The Invader assay was performed as previously described. 40 The polymerase chain reaction (PCR) mixture for the TaqMan-ASA method contained 7.5 ml of 2 Â TaqMant 
Statistical analysis
In all genotypic, haplotypic, and diplotypic distribution analyses, P-values were calculated using Fisher's exact test. Allele frequencies in asthma patients and controls were compared by the contingency w 2 test. ORs were estimated according to Brown. 41 Corrections of ORs for age and sex were performed with logistic regression formula in the adult case analysis. Because the range of age of the controls (18-81 years) was not comparable with child cases (1-17 years), CI of OR becomes very broad in the childhood asthma analysis. Thus, ORs corrected for only sex were presented in childhood asthma analysis. As shown in Tables 3 and 5, 42 and HAPLOTYPERt (http://www.people.fas.harvard.edu/~junliu/ Haplo/docMain.htm) 43 were used. Haplotype frequencies between cases and controls were evaluated both by a whole distribution with Fisher's exact test and by w 2 tests of one haplotype against others (haplotype-wise test). In the association study between a single SNP and asthma or an asthma-related phenotype, we performed many statistical tests; therefore, inflation of the false-positive results (type 1 error) is a concern. Because all eight SNPs were significantly in linkage disequilibrium (Table 2) and asthma-related phenotypes (seven variables for children and seven variables for adults) are significantly related, 28 the simple multiplication of P-values by the number of SNPs or phenotypes tested is too conservative and the appropriate value for the correction is not evident. Thus, to deal with the multiple comparisons, we did not apply Bonferroni corrections but rather set the significant P-value at 0.01 rather than 0.05. In the haplotype-wise test, comparisons were repeated as many as 26 times (25 haplotypes and 'another minor haplotype'; Tables 4 and  5 ). In this case, we assumed each comparison was independent and performed the Bonferroni correction (raw P-values were multiplied by 26). The corrected Pvalues were designated as P c . The P c -values less than 0.01 were judged to be significant. The software SPSSt version 11.0J (SPSS Japan Inc., Tokyo, Japan) was used for all statistical analyses. 
